ArticleBMC geriatrics2026
Prevalence of sensory impairments and associations with symptoms of anxiety and depression in US older adults.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundSensory impairments are common in older adults and may contribute to mental health problems. However, nationally representative data on sensory impairments, especially objective measured impairments, and their associations with emotional symptoms remain limited. This study aims to evaluate the age-specific prevalence of sensory impairments and investigate their short-term prospective associations with depression and anxiety among older adults living in the United States.
methodsData were from the round 12 (2022) and 13 (2023) of the National Health and Aging Trends Study (NHATS), a nationally representative survey of Medicare beneficiaries ≥ 65 years in the United States. We included 5,020 participants with objective vision/hearing tests and mental health questionnaires. Age-specific prevalence of objective and self-reported sensory impairments was calculated. Cox proportional hazards regression models, accounting for the complex survey design, were used to evaluate the short-term prospective associations between sensory impairments and depression and anxiety symptoms, measured via Patient Health Questionnaire-4.
resultsOf the 5,020 participants (weighted: 54.8% female; 79.3% White), the prevalence of objectively measured vision impairment (VI), hearing impairment (HI), and dual sensory impairment (DSI) was 30.9%, 20.9%, and 8.6%, respectively. However, the self-reported prevalence was substantially lower, with only 7.1%, 16.8% and 1.5% reporting VI, HI and DSI, respectively. Longitudinal analyses included 4,453 participants without baseline depressive symptoms and 4,519 without baseline anxiety. Compared with those without impairments, objective VI alone (adjusted hazards ratio[aHR], 2.29; 95% CI, 1.41-3.72), HI alone (aHR, 2.14; 95% CI, 1.24-3.68) and DSI (aHR, 2.40; 95% CI, 1.17-4.93) were significantly associated with an increased risk of anxiety symptoms over a median follow-up of 10.1 months. No significant associations were observed for depressive symptoms.
conclusionsObjectively measured sensory impairments were highly prevalent among US older adults and were associated with an increased risk of anxiety, but not depressive symptoms over a short follow-up duration. Self-reports considerably underestimated true prevalence of mild- to- moderate impairment, emphasizing the need for routine objective assessment in clinical practice and research.
Indexed as
Identifiers
42477549What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.